Literature DB >> 6091187

Prostaglandin-generating factor of anaphylaxis induces mucous glycoprotein release and the formation of lipoxygenase products of arachidonate from human airways.

Z Marom, J H Shelhamer, L Steel, E J Goetzl, M Kaliner.   

Abstract

The effects of prostaglandin-generating factor of anaphylaxis (PGF-A) upon the lipoxygenation of arachidonic acid and the promotion of mucous glycoprotein secretion by human airways were analyzed concurrently in order to determine the role that lipoxygenase products play in the secretion of mucus which accompanies immediate hypersensitivity reactions of airways. PGF-A enhanced both mucous glycoprotein release and the 5- and 15-lipoxygenation of arachidonic acid as well as the formation of leukotriene B4 (LTB4) with similar dose-response relationships. The capacity of PGF-A to stimulate mucous glycoprotein release was inhibited by ETYA but not by indomethacin, suggesting that PGF-A stimulated lipoxygenase products may be involved. Lipoxygenase products of arachidonic acid thus may serve as mediators of the enhancement of mucus secretion from human airways in response to PGF-A.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091187     DOI: 10.1016/0090-6980(84)90115-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  3 in total

1.  The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling.

Authors:  Yeon Ho Choi; Sang-Nam Lee; Hiroki Aoyagi; Yasundo Yamasaki; Jung-Yoon Yoo; Boryung Park; Dong Min Shin; Ho-Geun Yoon; Joo-Heon Yoon
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 2.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01

3.  Human monocyte-derived mucus secretagogue.

Authors:  Z Marom; J H Shelhamer; M Kaliner
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.